Compared with the blank group,, Fas/FasL and Caspase3 protein expressions were decreased, and EGFL7, ERK, P-ERK, Bcl-2 protein expressions were significantly increased in the miR-126 inhibitors group (all P < 0.05), suggesting that the low EGFL7 expression inhibited the activation of the ERK signaling pathway, promoting the expression of pro-apoptotic factors and HCC cell apoptosis [20]. The gene discussed is EGFL7; the disease is hepatocellular carcinoma.